What are analysts Suggestions on: Mast Therapeutics, Inc. (NYSEMKT:MSTX)


Mast Therapeutics, Inc. (NYSEMKT:MSTX) reported the earnings of $-0.04/Share in the last quarter where the estimated EPS by analysts was $-0.05/share. The difference between the expected and actual EPS was $0.01/share, which represents an Earnings surprise of 20%.

Many analysts are providing their Estimated Earnings analysis for Mast Therapeutics, Inc. and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $-0.03/share. These analysts have also projected a Low Estimate of $-0.04/share and a High Estimate of $-0.01/share.

Some buy side analysts are also providing their Analysis on Mast Therapeutics, Inc., where 1 analysts have rated the stock as Strong buy, 2 analysts have given a Buy signal, 2 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. 2 Analysts reported that the Price Target for Mast Therapeutics, Inc. might touch $3 high while the Average Price Target and Low price Target is $2.75 and $2.5 respectively.

To analyze a stock, one should look for Upgrades and Downgrades of a stock. Mast Therapeutics, Inc. got Downgrade on 21-Sep-16 where investment firm Maxim Group Downgrade the stock from Buy to Hold.

Mast Therapeutics, Inc. closed its last trading session at $0.09 with the loss of -7.86%. The Market Capitalization of the company stands at 20.34 Million. The Company has 52-week high of $0.71 and 52-week low of $0.07. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 5.44% where SMA50 and SMA200 are -14.97% and -71.62% respectively. The Company Touched its 52-Week High on Sep 6, 2016 and 52-Week Low on Nov 18, 2016.

The Relative Volume of the company is 0.5 and Average Volume (3 months) is 10.69 million. Mast Therapeutics, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -83.7%. The Return on Equity (ROE) value stands at -216.9%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Mast Therapeutics, Inc. currently shows a Weekly Performance of -10.83%, where Monthly Performance is 7%, Quarterly performance is -80.55%, 6 Months performance is -80.09% and yearly performance percentage is -80.55%. Year to Date performance value (YTD perf) value is -79.62%. The Stock currently has a Weekly Volatility of 11.06% and Monthly Volatility of 10.30%.